Journal profile · Medicine-Oncology
JNCI Cancer Spectrum
ISSN 2515-5091 · Oxford University Press · United Kingdom
JNCI Cancer Spectrum: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 6 (journal website); fully open access; APC about USD 1,951; median 126 days to acceptance (102 articles, last 24 months); 123 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
JNCI Cancer Spectrum is published by Oxford University Press and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Global Cancer Incidence and Screening, Cancer survivorship and care and Cancer Risks and Factors, together about 27.5% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
JNCI Cancer Spectrum is a peer-reviewed, open-access journal that publishes 6 issues per year online. The journal publishes manuscripts that describe new findings of particular significance across a full range of clinical and translational cancer research, including prevention, screening, and treatment, as well as clinically relevant epidemiologic, public health, and policy research. In addition to novel results, the journal will also consider studies with meaningful confirmatory or negative findings, and it encourages systematic reviews, meta-analyses, and expert reviews of important topics. The journal also invites scholarly manuscripts discussing emerging hypotheses and research priorities. The journal employs a process of rigorous yet rapid review of submitted manuscripts so that findings of high scientific and medical interest can be published with minimum delay. JNCI Cancer Spectrum is published by Oxford University Press and is not affiliated with the United States National Cancer Institute (NCI). Journal metrics Citation metrics Clarivate 2025 Impact Factor 4.8 2025 5 Year Impact Factor 4.6 Oncology (Rank by Impact Factor) 92/333 2025 Cited Half-Life 4.4 years 2025 Immediacy Index 0.7 2025 Eigenfactor Score 0.00667 2025 Article Influence Score 1.811 Scopus 2025 CiteScore 6.0 Oncology (Rank by CiteScore) 111/428 Cancer Research (Rank by CiteScore) 96/233 2025 Source Normalized Impact per Paper (SNIP) 1.312 Readership 2025 Full Text Usage 289,664 Peer Review and Production 2025 Median days from acceptance to publication 13.5 days About metrics Disclaimer Statements of fact and opinion in the articles in JNCI Cancer Spectrum are those of the respective authors and contributors and not of the Journal or Oxford University Press. Neither Oxford University Press nor the Journal make any representation, express or implied, in respect of the accuracy of the material in the Journal and cannot accept any legal responsibility or liability for any errors or omissions that may be made. Readers should make their own evaluation as to the appropriateness or otherwise of the information included.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Oncology
Editor-in-chief James B. YuPublisher website
Editorial board by country: none in mainland China; most named United States 46, Australia 7, India 3, Canada 3, Denmark 2 (64 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Global Cancer Incidence and ScreeningMedicine10.9%
- Cancer survivorship and careMedicine9.2%
- Cancer Risks and FactorsMedicine7.4%
- Economic and Financial Impacts of CancerEconomics, Econometrics and Finance5.5%
- Childhood Cancer Survivors' Quality of LifeMedicine5.1%
- BRCA gene mutations in cancerBiochemistry, Genetics and Molecular Biology5%
- Colorectal Cancer Screening and DetectionMedicine4.6%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPMCPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 6Publisher website ·
- 5-year impact factor (publisher) 2025
- 4.6Publisher website ·
- CiteScore 2026-06
- 6LetPub ·
- CiteScore (publisher) 2025
- 6Publisher website ·
- SJR 2026-06
- 1.72LetPub ·
- SNIP 2026-06
- 1.31LetPub ·
- h-index
- 55OpenAlex ·
- i10-index
- 416OpenAlex ·
- 2-year mean citedness
- 3.69OpenAlex ·
- Self-citation rate
- 2.1%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 109LetPub ·
- Downloads per year (publisher) 2025
- 289,664Publisher website ·
Articles by year OpenAlex count · 978 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 102 | 102 | 41 |
| 2025 | 123 | 123 | 306 |
| 2024 | 131 | 131 | 965 |
| 2023 | 109 | 109 | 1,847 |
| 2022 | 89 | 89 | 1,119 |
| 2021 | 104 | 104 | 2,175 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
126 daysMedian, submission to acceptance · P25–P75 93 days – 167 days
- Acceptance to online
- median 20 days (20 articles)
- Submission to online
- median 129 days
- Sample
- 102 articles with submission and acceptance dates (259 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 18 weeksLetPub ·
- Acceptance to publication
- 13.5 daysPublisher website ·
- Submission to publication (journal-reported)
- about 18 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,951 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,050 | — | — | |
| LetPub | USD 1,951 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- USD 3,625
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 3,000 words
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
- Highlights
- Optional
- Graphical abstract
- Optional
- Cover letter
- Optional
Article types accepted19, with length limits
- articlesArticles provide the most extensive description of new findings of major importance. An Article should contain 3000 or fewer words, not counting the abstract, r…Length not stated
- brief communicationArticles Articles provide the most extensive description of new findings of major importance. An Article should contain 3000 or fewer words, not counting the ab…Length not stated
- brief communicationsBrief Communications are concise descriptions of new findings of general interest. A Brief Communication should contain 1500 or fewer words, not counting abstra…Length not stated
- commentariesTopical items under this heading convey to the reader, in relatively non-technical style, a summary of current activities or issues that bear on some aspect of …Length not stated
- commentaryManuscript Type Word limit Abstract word limita References Figures. tables, and boxes Article 3000 250 No limit 8 Brief communication 1500 150 No limit 2 Commen…main text ≤ 4,000 words
- correspondenceArticles Articles provide the most extensive description of new findings of major importance. An Article should contain 3000 or fewer words, not counting the ab…figures and tables ≤ 1
- editorialManuscript Type Word limit Abstract word limita References Figures. tables, and boxes Article 3000 250 No limit 8 Brief communication 1500 150 No limit 2 Commen…main text ≤ 1,500 words
- editorialsEditorials usually contain about 1500 words in the main text (not counting the reference list).Length not stated
- in memoriamThese manuscripts honor the life, legacy, and contributions of cancer researchers or clinicians who have recently passed away.Length not stated
- invited responsesResponses should be no more than 500 words, not counting the reference list (seven references maximum), and one figure legend or table may be included.Length not stated
- letterArticles Articles provide the most extensive description of new findings of major importance. An Article should contain 3000 or fewer words, not counting the ab…Length not stated
- letters to the editorArticles Articles provide the most extensive description of new findings of major importance. An Article should contain 3000 or fewer words, not counting the ab…Length not stated
- meta-analysisArticles Articles provide the most extensive description of new findings of major importance. An Article should contain 3000 or fewer words, not counting the ab…Length not stated
- minireviewsA MiniReview should contain 2000 or fewer words, not counting abstract, reference list, tables, and figure legends.Length not stated
- opinionArticles Articles provide the most extensive description of new findings of major importance. An Article should contain 3000 or fewer words, not counting the ab…Length not stated
- original articleArticles Articles provide the most extensive description of new findings of major importance. An Article should contain 3000 or fewer words, not counting the ab…Length not stated
- reviewManuscript Type Word limit Abstract word limita References Figures. tables, and boxes Article 3000 250 No limit 8 Brief communication 1500 150 No limit 2 Commen…Length not stated
- reviewsA Review should contain 6000 or fewer words, not counting abstract, reference list, tables, and figure legends.Length not stated
- systematic reviewArticles Articles provide the most extensive description of new findings of major importance. An Article should contain 3000 or fewer words, not counting the ab…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints, Self-archiving, Trial registration / reporting guidelines
- Authorship Authorship
Authorship is limited to those who have made a significant contribution to the design and execution of the work described. Any contributors whose participation does not meet the criteria for authorship should be acknowledged but not listed as an author. For a detailed definition of authorship, please see the International Committee of Medical Journal Editors (ICMJE) definitions of authors and cont…
Source ↗Publisher website ·- Conflicts of interest Disclosure of potential conflicts of interest
Authors The Journal requires all authors to disclose any potential conflict of interest at the point of submission. It is the responsibility of the corresponding author to ensure that conflicts of interest of all authors are declared to the Journal. A conflict of interest exists when the position, activities, or relationships of an individual, whether direct or indirect, financial or non-financial…
Source ↗Publisher website ·- Data availability Availability of data and materials
Data repository encouraged to issue DOIs. Model summary
The Journal requires all authors, where ethically possible, to publicly release all data and software code underlying any published paper as a condition of publication. Authors are required to include a data availability statement in their paper. When data and software underlying the research article are available in an online source, authors should include a full citation in their reference list.…
Source ↗Publisher website ·- Publication ethics Screening for misconduct
Manuscripts may be screened using iThenticate and Similarity Check to help detect publication misconduct including plagiarism and redundant publication. Manuscripts may also be screened, including with services provided by third parties, to help detect integrity issues such as inappropriate image alteration and papermill activity.
Source ↗Publisher website ·- License & copyright Open Government Licence
The Open Government Licence is an open licencing model for content produced by employees of UK Crown bodies allowing users to copy, publish, distribute, adapt and transmit the Information for commercial and non-commercial purposes. For additional information visit the gov.uk information on the Open Government Licence.
Source ↗Publisher website ·- Open access Open access charges
Please see the details of open access licences and charges. As the Journal is fully open access, you must pay the open access charge or request to use an institutional agreement to pay the open access charge through our licencing and payment portal, SciPris. Please note that prices are subject to change. All stated charges are exclusive of any applicable value added tax, goods and services tax and…
Source ↗Publisher website ·- Peer review Peer review process
Single anonymized peer review; authors known to reviewers, reviewers hidden from authors. Model summary
The Journal uses the ANSI/NISO Standard Terminology for Peer Review. If you would like further description of the peer review terms used here, please refer to the most recent standard definitions. If further clarification is needed, please contact the editorial office at jncics.editorialoffice@technicaeditorial.com. Peer review summary: Identity transparency: single anonymized Reviewer interacts w…
Source ↗Publisher website ·- Preprints Preprints
Preprints allowed; does not prevent submission. Model summary
As an author, you retain the right to make an Author’s Original Version (preprint) available through various channels and this does not prevent submission to the Journal. If accepted, you are required to update the status of any preprint, including adding your published paper’s DOI. For full details on allowed channels and updating your preprint, please see our Author self-archiving policy.
Source ↗Publisher website ·- Self-archiving Self-archiving
Self-archiving refers to posting a copy of your work on a publicly accessible website or repository. Under certain circumstances, you may self-archive versions of your work on your own webpages, on institutional webpages, and in other repositories. For information about the Journal's policy, and to learn which version(s) of your paper are acceptable for self-archiving, please see our Author self-a…
Source ↗Publisher website ·- Trial registration / reporting guidelines Reporting guidelines
Authors are encouraged to follow published standard reporting guidelines for the study discipline. Please refer to this table. Study discipline Reporting guidelines/reference to consult Animal studies ARRIVE Prognostic markets REMARK Diagnostic markers STARD Meta-analyses of observational studies in medicine MOOSE. Stroup DF, et al. JAMA 2000;283:2008-2012 Systematic reviews and meta-analyses of h…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Oxford University Press
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2515-5091
- Latest issue on the website
- Volume 10, Issue 5 (October 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about JNCI Cancer Spectrum
What CAS zone is JNCI Cancer Spectrum in?
In the 2025 upgraded edition of the CAS Journal Ranking, JNCI Cancer Spectrum is in Zone 3 of Medicine, and in Zone 3 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JNCI Cancer Spectrum?
The journal's website gives an impact factor of 6 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 6, h-index 55.
How long does peer review take at JNCI Cancer Spectrum?
Based on the dates recorded on 102 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 126 days (interquartile range 93–167 days); authors report an average review time of about 18 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of JNCI Cancer Spectrum?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 3,000 words; Reference style: Numbered, in order of citation; Suggested reviewers: Optional; Highlights: Optional; Graphical abstract: Optional; Cover letter: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of JNCI Cancer Spectrum based?
Of the 64 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (46), Australia (7) and India (3). Counted from the institutions listed on the board page; for reference only.
Which databases index JNCI Cancer Spectrum?
According to LetPub and DOAJ records, JNCI Cancer Spectrum is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science, MEDLINE and PMC; that list has not been checked against each database.
Is JNCI Cancer Spectrum open access, and what is the APC?
JNCI Cancer Spectrum is a fully open-access journal. APC about USD 1,951.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .